Green Tea and Cancer: What Does the Science Say?

Green tea contains compounds that can kill cancer cells in a petri dish, but the leap from laboratory promise to proven human benefit remains stubbornly incomplete. Decades of research have identified a potent catechin called EGCG as the star molecule, and population studies hint at modest protective effects for certain cancers, yet randomized clinical trials in humans have mostly failed to deliver the clear-cut results that headlines often imply. The picture is more interesting, and more complicated, than either “green tea cures cancer” or “green tea does nothing.”

The Molecule Behind the Claims

Green tea is made from the leaves of Camellia sinensis, the same plant that produces black and oolong tea. The difference is processing: green tea leaves are steamed or pan-fired shortly after harvesting, which preserves a family of antioxidant compounds called catechins. The most abundant and most studied of these is epigallocatechin-3-gallate, universally abbreviated as EGCG.¹ EGCG makes up roughly half of the total catechin content in a typical cup of green tea, and it has been the focus of thousands of studies investigating effects on everything from heart disease to neurodegeneration to cancer.²

What EGCG Does to Cancer Cells in the Lab

In cell culture experiments, EGCG hits cancer cells on multiple fronts. It interferes with receptor tyrosine kinases, which are proteins on the cell surface that tell cancer cells to grow and divide. EGCG blocks the activation of several of these receptors, including EGFR and HER2, and downstream signaling pathways that promote cell survival.³ The practical upshot in these experiments is that cancer cells stop dividing and start dying through a process called apoptosis, which is the cell’s built-in self-destruct program.

EGCG also inhibits enzymes called matrix metalloproteinases (MMPs), which tumors use to chew through surrounding tissue and spread. Lab studies have shown that EGCG specifically suppresses MMP-2 and MMP-9, enzymes linked to tumor invasion, and blocks the activation of pro-MMP-2 in human brain tumor cell lines.⁴ Separately, EGCG has been shown to directly inhibit the activity of MT1-MMP, another enzyme involved in tissue remodeling that tumors exploit.⁵

There is also an epigenetic angle. EGCG can reduce DNA methylation and increase histone acetylation in skin cancer cells, changes that reactivate tumor-suppressor genes that the cancer had silenced.⁶ And under certain conditions, EGCG can flip from antioxidant to pro-oxidant, generating reactive oxygen species that damage cancer cell DNA and trigger cell death, as demonstrated in lung cancer cells.⁷

All of this sounds impressive, and it is, if you are a cancer cell floating in a dish of concentrated EGCG. The problem is that the concentrations used in most of these experiments are far higher than what your body actually achieves after drinking tea.

The Bioavailability Problem

This is arguably the most important piece of the puzzle. Most lab studies expose cells to EGCG concentrations between 20 and 200 micromolar, but a realistic blood level after drinking a couple of cups of green tea or taking a supplement is well below 10 micromolar.⁸ That is a gap of at least two-fold, often twenty-fold. When researchers talk about EGCG’s “anti-cancer properties,” they are usually describing effects at concentrations your bloodstream never reaches from normal tea consumption.

Making things harder, EGCG is poorly absorbed in the gut. Eating food at the same time cuts absorption substantially: one study found that taking EGCG capsules with a light breakfast reduced the amount reaching the bloodstream by roughly two-thirds compared to taking them on an empty stomach.⁹ Fasting before taking a purified EGCG supplement gives the best pharmacokinetic profile in terms of peak blood levels.¹⁰ But even under ideal absorption conditions, the concentrations remain far below what kills cancer cells in most lab setups.

Most of the EGCG you ingest ends up in the large intestine, where gut bacteria break it down into smaller molecules like phenolic acids and valerolactones. These breakdown products are actually better absorbed than EGCG itself, and some researchers believe they may be the real drivers of whatever health benefits green tea provides.¹¹ That would help explain a nagging puzzle: why population studies sometimes find protective associations with green tea consumption even though blood levels of intact EGCG are so low. The metabolites produced by gut bacteria, not the parent compound, could be doing much of the work.¹² But this line of research is still young, and the variation in gut bacteria from person to person means results could differ dramatically between individuals.¹³

What Human Studies Actually Show

The evidence in people falls into two categories: observational studies that track tea-drinking habits in large populations, and clinical trials that give people green tea extracts and measure specific outcomes.

For breast cancer, a systematic review and meta-analysis of observational studies found that green tea consumption was associated with about a 15% lower risk, with a stronger signal for reduced recurrence in early-stage disease.¹⁴ A separate large study in Chinese women reported a roughly 12% reduction in breast cancer risk among regular green tea drinkers, with the pattern holding for both premenopausal and postmenopausal women, though the association was stronger in premenopausal women.¹⁵ These are promising numbers, but an earlier systematic review flagged that the evidence is drawn from a small number of studies with no clinical trial data, no consistent dose-response pattern, and possible confounding from other lifestyle differences among tea drinkers.¹⁶

For prostate cancer, a randomized placebo-controlled trial gave men at high risk (those with precancerous prostate lesions) a daily supplement containing 400 mg of EGCG for one year. The main result was negative: prostate cancer rates were not significantly different between the supplement and placebo groups. A secondary analysis did find fewer precancerous changes in a subgroup, and PSA levels dropped slightly on the supplement, but the trial’s primary endpoint was not met.¹⁷

For colorectal cancer, the story has a similarly encouraging-but-incomplete pattern. One trial in patients who had already had precancerous polyps removed found that green tea extract cut the recurrence of new polyps roughly in half compared to controls.¹⁸ But a larger European trial, MIRACLE, tested 150 mg of EGCG twice daily over three years and found only a trend toward fewer polyps that was not statistically significant.¹⁹ The supplement was well tolerated, but the effect was too small to reach the threshold of confidence researchers require before declaring something works.

Taken together, the human data shows a consistent lean in green tea’s favor, but the evidence is not strong enough to call it a cancer preventive in any formal medical sense. The observational studies cannot prove cause and effect, and the clinical trials so far have been relatively small and have produced mixed or borderline results.

The Temperature Trap

One area where the green tea story gets counterintuitive is esophageal cancer. In some regions of China and Central Asia, where people drink tea at very high temperatures, researchers have actually found an increased risk of esophageal cancer among tea drinkers. A meta-analysis reported that drinking tea at higher temperatures was associated with about 79% higher odds of esophageal cancer.²⁰

A study in two Chinese counties found that green tea drinking initially appeared to raise esophageal cancer risk, but once the researchers adjusted for tea temperature, the association vanished. The culprit was the heat, not the tea itself.²¹ A large UK Biobank analysis confirmed the pattern: among people who preferred their hot beverages at “very hot” temperatures and drank more than eight cups a day, the risk of esophageal squamous cell carcinoma was more than five times higher compared to people who drank warm or fewer beverages.²²

The takeaway is practical: if you drink green tea at a comfortable temperature, the thermal risk is not an issue. But if you routinely gulp near-boiling tea, the chronic thermal injury to the esophagus is a genuine and well-documented cancer risk factor, and no amount of EGCG will offset that damage. Letting your tea cool for a few minutes before drinking is a simple way to eliminate the concern entirely.

Your Genes May Decide How Much You Benefit

One reason green tea studies produce inconsistent results may be genetic variation among people. A key enzyme called COMT (catechol-O-methyltransferase) breaks down tea catechins in the body. People carry different versions of the gene for this enzyme, some producing a high-activity form that eliminates catechins quickly and others producing a low-activity form that clears them slowly.

In a study of Asian-American women, those who carried at least one copy of the low-activity COMT gene and drank tea had about half the risk of breast cancer compared to non-tea drinkers with the same genotype. Among women who were homozygous for the high-activity version, tea drinking made no difference at all to breast cancer risk.²³ The logic is straightforward: if your body clears catechins slowly, they linger longer and have more time to exert whatever protective effects they have.

This pattern extends beyond breast cancer. A study on lung cancer found that among smokers, green tea drinkers with the high-activity COMT genotype had nearly six times the lung cancer risk compared to green tea drinkers with the low-activity genotype.²⁴ Supporting the mechanism, a separate study showed that men with the low-activity COMT genotype excreted less tea polyphenols in urine, suggesting they retain more in circulation.²⁵

You almost certainly do not know your COMT genotype, and no one is suggesting you get tested before deciding whether to drink green tea. But this research explains why a blanket statement like “green tea prevents cancer” is misleading. For some people, the biological benefit may be real and meaningful. For others with different genetics, the same amount of tea might do very little. This kind of variation gets averaged out in large studies, diluting whatever real signal exists.

Safety, Supplements, and Drug Interactions

Green tea as a brewed beverage has an excellent safety record. The concerns arise with concentrated green tea extract supplements, especially at high doses taken on an empty stomach. A systematic review of safety data found that the liver is the primary organ at risk, and that liver-related side effects are dose-dependent and strongly associated with taking large bolus doses of catechin-rich supplements, not with drinking tea normally.²⁶

Supplement quality is another concern. Testing of commercial green tea dietary supplements found that only about a third of single-ingredient products consistently passed basic disintegration tests, and in dissolution testing (which measures whether the EGCG actually gets released from the pill), only six out of twenty single-ingredient products passed.²⁷ This means the EGCG in some supplements may never actually become available for absorption, making the pill functionally useless regardless of what the label says.

Perhaps the most alarming safety finding involves a specific drug interaction. EGCG directly blocks the cancer drug bortezomib, which is used to treat multiple myeloma and certain lymphomas. Lab studies showed that EGCG chemically reacts with bortezomib and prevents it from working, completely neutralizing its ability to kill tumor cells.²⁸ This effect is specific to boronic acid-based proteasome inhibitors and does not extend to all chemotherapy drugs, but it is a stark example of why cancer patients should discuss any supplement use, including green tea extracts, with their oncologist.²⁹

On the flip side, some early research suggests EGCG could enhance the effects of certain other cancer treatments. Lab studies have reported additive or synergistic effects when EGCG is combined with conventional therapies, and its anti-inflammatory properties may help reduce treatment side effects.³⁰ But these findings are mostly from cell culture and animal studies. The bortezomib interaction is a reminder that “natural” does not mean “harmless alongside other treatments.”

Green Tea Versus Black Tea

Since both come from the same plant, people often wonder whether black tea offers similar benefits. The key difference is oxidation during processing. Green tea preserves the original catechins, while black tea’s catechins get converted into larger molecules called theaflavins and thearubigins. Green tea ends up with significantly higher total phenolic content, flavonoid content, and antioxidant activity compared to black tea.³¹

In terms of cancer research specifically, the evidence for green tea is substantially stronger. After consumption of green tea, higher concentrations of polyphenols reach the bloodstream, whereas black tea’s larger polymer molecules are poorly absorbed and get broken down into phenolic acids by gut bacteria instead.³² That said, black tea is not without activity. In a mouse model of breast cancer, both green tea catechins and black tea theaflavins reduced tumor size by about 40% and increased cancer cell death, though the doses and mechanisms differed.³³ If you prefer black tea, you are not getting zero benefit, but the body of evidence pointing to anti-cancer effects is thinner and less consistent than what exists for green tea.

What You Can Reasonably Conclude

The honest state of the science is this: green tea contains a biologically active compound that can kill cancer cells in the laboratory through multiple well-understood mechanisms. Population-level data from observational studies suggests that regular green tea consumption is associated with modestly lower risks for certain cancers, particularly breast cancer. But randomized clinical trials, which are the gold standard, have not yet confirmed that green tea or EGCG supplements prevent cancer in humans. The trials run so far have been small, and the results have ranged from borderline suggestive to clearly negative.

Several factors muddy the waters: the bioavailability of EGCG is low, individual genetics (especially COMT status) likely determine who benefits most, gut bacteria vary widely from person to person and influence how tea compounds are metabolized, and supplement quality is inconsistent. These are not reasons to dismiss green tea research. They are reasons to be cautious about strong claims in either direction. Drinking a few cups of green tea a day is safe for most people, inexpensive, and comes with other well-established health benefits. Treating it as a cancer preventive or, worse, as an alternative to evidence-based cancer treatment, is not supported by the current evidence.

When Supplements Might Actually Cause Harm

The irony of the green tea supplement market is that the products most aggressively marketed as cancer-protective are the ones most likely to cause problems. High-dose EGCG supplements taken in bolus form on an empty stomach achieve the best absorption, as noted earlier, but they also carry the highest risk of liver toxicity. Several countries have issued safety warnings about concentrated green tea extract products, and some formulations have been pulled from shelves after reports of liver damage.

The disconnect between brewed tea and concentrated pills is significant. A cup of green tea typically contains somewhere around 50 to 100 mg of EGCG, diluted in water and consumed alongside other food compounds. A supplement capsule might pack 400 to 800 mg of EGCG into a single dose that hits the liver all at once. The clinical trials that found EGCG to be well tolerated generally used moderate doses around 300 to 400 mg per day, and even then they monitored liver function throughout.¹⁷ If you are considering a green tea supplement for any reason, choosing a product from a reputable manufacturer with third-party testing is worth the effort, given that a substantial fraction of commercial products fail basic quality tests for whether they even release their active ingredient properly.